Global
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -92.27 B
|
Sept. 30, 2024 | USD 93.00 | 1.03% |
|
United States |
|
2 |
USD -14.94 B
|
Dec. 31, 2023 | USD 97.87 | 1.09% |
|
South Korea |
|
3 |
USD -9.95 B
|
Dec. 31, 2023 | USD 166.75 | 2.20% |
|
South Korea |
|
4 |
USD -8.21 B
|
Sept. 30, 2024 | USD 744.91 | -6.59% |
|
United States |
|
5 |
USD -5.76 B
|
Dec. 31, 2023 | USD 81.56 | -2.90% |
|
Denmark |
|
6 |
USD -5.65 B
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
7 |
USD -5.52 B
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
8 |
USD -3.78 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
9 |
USD -3.55 B
|
Sept. 30, 2024 | USD 543.74 | 0.48% |
|
United States |
|
10 |
USD -3.42 B
|
Sept. 30, 2024 | USD 99.65 | -1.32% |
|
United States |
|
11 |
USD -3.34 B
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
12 |
USD -3.18 B
|
March 31, 2024 | USD 26.08 | -0.18% |
|
Japan |
|
13 |
USD -3.07 B
|
March 31, 2024 | USD 20.70 | -1.48% |
|
Japan |
|
14 |
USD -3.04 B
|
Dec. 31, 2023 | USD 20.20 | -1.60% |
|
Germany |
|
15 |
USD -3.04 B
|
Sept. 29, 2024 | USD 26.41 | -1.46% |
|
United States |
|
16 |
USD -2.98 B
|
Dec. 31, 2023 | USD 15.79 | -2.73% |
|
United Kingdom |
|
17 |
USD -2.92 B
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
18 |
USD -2.75 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
19 |
USD -2.29 B
|
June 30, 2024 | USD 30.03 | 0.13% |
|
United States |
|
20 |
USD -2.24 B
|
Sept. 30, 2024 | USD 113.02 | -0.15% |
|
United States |
|
21 |
USD -2.23 B
|
Dec. 31, 2023 | USD 145.16 | 0.75% |
|
Germany |
|
22 |
USD -2.01 B
|
Sept. 30, 2024 | USD 92.63 | 1.22% |
|
United States |
|
23 |
USD -1.96 B
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
24 |
USD -1.86 B
|
Dec. 31, 2023 | USD 0.53 | 1.44% |
|
China |
|
25 |
USD -1.81 B
|
March 31, 2024 | USD 4.96 | -0.98% |
|
Japan |
|
26 |
USD -1.70 B
|
Oct. 25, 2024 | USD 85.25 | 4.23% |
|
Ireland |
|
27 |
USD -1.56 B
|
Dec. 31, 2023 | USD 122.81 | -2.58% |
|
Canada |
|
28 |
USD -1.43 B
|
Sept. 30, 2024 | USD 285.03 | 0.91% |
|
United States |
|
29 |
USD -1.32 B
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
30 |
USD -1.28 B
|
Sept. 27, 2024 | USD 237.62 | -0.94% |
|
United States |
|
31 |
USD -1.26 B
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
32 |
USD -1.25 B
|
Dec. 31, 2023 | USD 35.88 | 1.39% |
|
Germany |
|
33 |
USD -1.23 B
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
34 |
USD -1.20 B
|
Sept. 30, 2024 | USD 55.74 | 0.69% |
|
United States |
|
35 |
USD -1.14 B
|
March 31, 2024 | USD 6.73 | -0.18% |
|
Japan |
|
36 |
USD -1.02 B
|
March 31, 2024 | USD 20.77 | -0.09% |
|
Japan |
|
37 |
USD -974.00 M
|
Sept. 30, 2024 | USD 267.10 | -1.14% |
|
United States |
|
38 |
USD -971.00 M
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
39 |
USD -931.08 M
|
Dec. 31, 2023 | USD 79.48 | 0.76% |
|
Saudi Arabia |
|
40 |
USD -888.00 M
|
Sept. 30, 2024 | USD 175.55 | -0.67% |
|
United States |
|
41 |
USD -869.80 M
|
Sept. 30, 2024 | USD 690.87 | -3.63% |
|
United States |
|
42 |
USD -859.04 M
|
Dec. 31, 2023 | USD 24.69 | -1.27% |
|
Japan |
|
43 |
USD -851.00 M
|
Dec. 31, 2023 | USD 82.92 | 0.05% |
|
Switzerland |
|
44 |
USD -848.89 M
|
Dec. 31, 2023 | USD 698.37 | 1.93% |
|
South Korea |
|
45 |
USD -812.69 M
|
Dec. 31, 2023 | USD 50.94 | -0.33% |
|
Japan |
|
46 |
USD -811.28 M
|
March 31, 2024 | USD 26.30 | 0.47% |
|
Japan |
|
47 |
USD -809.00 M
|
Sept. 30, 2024 | USD 127.63 | -1.27% |
|
United States |
|
48 |
USD -778.70 M
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
|
49 |
USD -777.01 M
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
50 |
USD -774.96 M
|
Sept. 30, 2024 | USD 52.62 | 1.24% |
|
Germany |
The Pharmaceuticals company with the highest Capital Expenditure is Coherent, Inc. (NYSE: COHR) at USD -92.27 B.
The Pharmaceuticals company with the lowest Capital Expenditure is ViroGates A/S (Copenhagen Stock Exchange: VIRO.CO) at USD 0.00.
The top 10 Pharmaceuticals companies the Global by Capital Expenditure are Coherent, Inc., SK Inc., LG Chem, Ltd., Eli Lilly and Company, Novo Nordisk A/S, Johnson & Johnson, Roche Holding AG, AstraZeneca PLC, UnitedHealth Group Incorporated and Merck & Co., Inc..
The bottom 10 Pharmaceuticals companies by Capital Expenditure are ViroGates A/S, Viking Therapeutics, Inc., Nuvectis Pharma, Inc., Exicure, Inc., Leap Therapeutics, Inc., Nuvalent, Inc., Verastem, Inc., SCWorx Corp., Corbus Pharmaceuticals Holdings, Inc. and PharmaCyte Biotech, Inc..